Clinical Trials in Easley, United States
Locations / Easley, United States
Delta Trials catalogs 49 clinical trials conducted in Easley, United States, making it a notable site of clinical research activity. These trials spanning 337 distinct medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations in Easley evolve over time.
49
Total Trials
337
Conditions
1
Terminated since 2020
Browse by condition (337 total)
- Acute myeloid leukemia 5 trialsAll Acute myeloid leukemia trials
- Advanced malignant solid neoplasm 4 trialsAll Advanced malignant solid neoplasm trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Metastatic malignant solid neoplasm 3 trialsAll Metastatic malignant solid neoplasm trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Stage iiia lung cancer ajcc v8 3 trialsAll Stage iiia lung cancer ajcc v8 trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- Myelodysplastic syndrome 3 trialsAll Myelodysplastic syndrome trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- Stage iiib lung cancer ajcc v8 3 trialsAll Stage iiib lung cancer ajcc v8 trials
- All B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2); bcr-abl1 trials
- Recurrent ovarian carcinoma 2 trialsAll Recurrent ovarian carcinoma trials
- Neuroendocrine tumor 2 trialsAll Neuroendocrine tumor trials
- Stage ii lung cancer ajcc v8 2 trialsAll Stage ii lung cancer ajcc v8 trials
- Exocrine pancreas carcinoma 2 trialsAll Exocrine pancreas carcinoma trials
- Recurrent malignant solid neoplasm 2 trialsAll Recurrent malignant solid neoplasm trials
- All Stage iii bladder urothelial carcinoma ajcc v6 and v7 trials
- Neuroendocrine tumor g2 2 trialsAll Neuroendocrine tumor g2 trials